Stroke Trial, Recruiting NCT06640101 Sponsor: Hong Kong Metropolitan University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06640101
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 40 years or older but younger than 80 years
  • People who are breathing on their own without mechanical assistance
  • People who have been clinically diagnosed with an ischemic stroke (caused by a blockage) and/or a haemorrhagic stroke (caused by bleeding)
  • People whose stroke occurred between 1 month and 12 months before joining the trial
  • People who have not had chest or abdominal surgery in the last 6 months
  • People who are able to understand and follow spoken instructions
  • People who have no facial weakness, or only mild facial weakness that does not stop the lips from closing properly
  • People who can sit upright without foot support for at least 30 seconds
  • People who have no significant cognitive (thinking or memory) impairment, as measured by a standard assessment called the MoCA with a score of 26 or above
  • People who are able to walk at least 10 metres on their own, with or without a walking aid

Who may not be able to join:

  • People who are experiencing an acute (sudden/recent) heart attack or acute heart failure
  • People who have acute pain anywhere in their body
  • People who have a respiratory (breathing) illness or show signs of impaired breathing, such as shortness of breath, low oxygen levels, chronic cough, or difficulty clearing mucus
  • People who have a long-term heart or cardiovascular condition affecting heart function
  • People who score 20 or above on a scale called the Trunk Impairment Scale, which measures trunk (torso) control and movement (confirm with trial site)
  • People who have a nasal feeding tube, a breathing tube in their throat (tracheal tube), or any other condition that would prevent the study procedures from being carried out or measured

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13603049475

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hong Kong Metropolitan University
Registry
ClinicalTrials.gov
Start date
21 February 2025
Est. completion
15 October 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diaphragmatic thickness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov